GlassScriptPhysician profile
Xujia A Smith
NPI 1912269564
$2,934.12
in general payments reported to CMS, 2019-2025
31 companies · $501 in 2025
The $501 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $242 · 2021: $291 · 2022: $426 · 2023: $518 · 2024: $412 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,431.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $509.88 | 2020-2025 | Veozah |
| Abbvie INC. | $379.69 | 2019-2023 | Liletta, Ubrelvy, Qulipta |
| Bayer Healthcare Pharmaceuticals INC. | $236.69 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $236.03 | 2021-2024 | |
| Hologic Sales and Service, LLC | $128.21 | 2019-2025 | Myosure Tissue Removal Device, Novasure, Aptima |
| Shield Therapeutics INC | $125.17 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $121.39 | 2023-2025 | Myfembree |
| Pfizer INC. | $110.83 | 2019-2023 | |
| Intuitive Surgical, INC. | $108.52 | 2025 | |
| Myovant Sciences INC. | $94.67 | 2021-2022 | |
| Evofem Biosciences, INC. | $82.25 | 2020-2022 | |
| Organon LLC | $78.91 | 2021-2025 | Jada System, Nexplanon |
| Asensus Surgical, INC. | $74.66 | 2019 | |
| Exeltis, USA INC. | $54.43 | 2021-2024 | Slynd |
| Exact Sciences Corporation | $54.09 | 2023 | Cologuard Collection Kit |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $48.85 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Agile Therapeutics, INC. | $48.35 | 2021-2022 | |
| Lupin INC. | $47.00 | 2019 | |
| Medtronic, INC. | $45.25 | 2024 | Truclear |
| Allergan, INC. | $44.21 | 2019 | |
| Therapeuticsmd, INC. | $44.07 | 2019-2020 | |
| Avion Pharmaceuticals | $43.09 | 2019-2023 | Balcoltra |
| Millicent US INC | $42.94 | 2019-2024 | Femring, Intrarosa |
| Covidien LP | $37.71 | 2020 | |
| Coopersurgical, INC. | $32.09 | 2023 | Summit Doppler |
| Daiichi Sankyo INC. | $23.74 | 2020 | |
| Amgen INC. | $21.43 | 2019 | |
| Lsi Solutions INC | $17.73 | 2024 | Fornisee |
| Roche Diagnostics Corporation | $15.60 | 2019 | |
| Coloplast Corp | $15.17 | 2020 | |
| Minerva Surgical, INC | $11.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xujia Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.